The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EDSA | +181.03% | -81.77% | -28.83% | -90% |
| S&P | +17.45% | +75.43% | +11.88% | +133% |
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its product candidate, EB01 is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis, a common, potentially debilitating condition and occupational illness. The company was founded on June 12, 2007 and is headquartered in Markham, Canada.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | -$25.46K | 40.9% |
| Market Cap | $11.83M | 103.1% |
| Market Cap / Employee | $696.12K | 0.0% |
| Employees | 17 | 6.3% |
| Net Income | -$2,247.67K | -39.0% |
| EBITDA | -$2,315.92K | -24.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $12.05M | 670.8% |
| Accounts Receivable | $431.33K | 23.0% |
| Inventory | 0 | 0.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $0.00K | 0.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -82.82% | 19.0% |
| Return On Invested Capital | -155.30% | 2.3% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2,087.33K | -37.6% |
| Operating Free Cash Flow | -$2,087.33K | -37.6% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 6.60 | 2.24 | 3.53 | 3.18 | 15.38% |
| Price to Tangible Book Value | -10.98 | 3.30 | 5.97 | 8.35 | -114.96% |
| Enterprise Value to EBITDA | -5.10 | -5.92 | -6.51 | -3.70 | 36.26% |
| Return on Equity | -58.8% | -69.6% | -99.6% | -96.4% | -36.03% |
| Total Debt | $0.00K | $0.00K | $0.00K | $0.00K | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
